Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in Behcet's Disease
NCT00700297Phase 2Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Aug 2002
- Primary completion
- Oct 2005
- Modality
- Nucleic Acid-Directed Small Molecules, Classical Binding Small Molecules, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Behcet's disease (BD) comparing Colchicine Sequence with Placebo Sequence (2 arms). Primary endpoint: Iranian Behcet's Disease Dynamic Activity Measurement at 8 months. Started Aug 2002; status: completed.
02
Drugs
colchicine
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT00700297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00700297.